The yield in the last year is 45%, and the yield in the last three years is 180%. Its performance ranks high among similar funds and its profitability is good. But the fluctuation is a bit big, and there are certain risks.
Ms. Glen, the fund manager, is a doctor of biomedical engineering from Northwestern University in the United States, and has more than 7 years of experience in securities and funds.
When buying a fund, we must find the right time, buy low and sell high. No fund will go up forever. The development prospect of the medical field is very good, and the medical and health mix between China and Europe has developed well in the medical field, which is suitable for long-term investment.
The market is risky and investment needs to be cautious.
The above are personal opinions and do not constitute investment advice.